Core Immunology Lab
Core Immunology Lab (CIL) specializes in developing immunology research tools, and initiating and stimulating innovative research projects to address emerging questions in immunologic diseases.
The Ernst Lab's research focuses on immunity to Mycobacterium tuberculosis (MTB), to inform the rational design and development of new TB vaccines.
Feeney lab strives to understand the human immune response to malaria and to harness this knowledge to improve vaccines, prevention strategies, and immunomodulatory therapies
Greenhouse Lab and EPPIcenter
Greenhouse Lab brings together laboratory and analytical tools to understand the transmission epidemiology and immunology of malaria, primarily in sub-Saharan Africa.
Henrich Lab focuses on various infectious diseases, with special emphasis on human immunodeficiency virus type-1 (HIV-1) and the characterization of latent HIV-1 reservoirs.
Research in the Hunt Lab has focused in the past on the definition of pathogenic mechanisms of viral diseases, particularly HIV disease.
The Javid lab is focused on leveraging understanding of the fundamental biology of Mycobacterium tuberculosis (Tb), and its interaction with the host, can be used for better Tb treatments.
The Rutishauser lab is focused on understanding the mechanisms that promote the formation of CD8+ T cell immunity to viral pathogens in humans, and the impact of developmental stage on antiviral immunity.
The Suliman lab is focused on identifying biological mechanisms underlying risk of progression to active tuberculosis (TB) disease, including host genetic, immune and metabolic pathways.